AxioMed Gets $18 Million Second Round

Taking advantage of a spate of high-value acquisitions of spinal implant developers and recent U.S. government approval of the first artificial spinal disk, AxioMed Spine raised $18 million in a second round of venture capital led by Thomas, McNerney & Partners.

The Deal (http://www.thedeal.com/NASApp/cs/ContentServer?pagename=TheDeal/TDDArticle/StandardArticle&c=TDDArticle&cid=1107993076359&r=InFs&p=M4YD5AR2)